ABTEC Stock Overview
Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Aqua Bio Technology ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr5.20 |
| 52 Week High | kr7.56 |
| 52 Week Low | kr2.39 |
| Beta | 0.79 |
| 1 Month Change | 27.14% |
| 3 Month Change | -7.14% |
| 1 Year Change | 4.00% |
| 3 Year Change | -53.98% |
| 5 Year Change | 94.03% |
| Change since IPO | -97.01% |
Recent News & Updates
Shareholder Returns
| ABTEC | NO Chemicals | NO Market | |
|---|---|---|---|
| 7D | 4.2% | -4.0% | 1.7% |
| 1Y | 4.0% | -25.1% | 4.1% |
Return vs Industry: ABTEC exceeded the Norwegian Chemicals industry which returned -24% over the past year.
Return vs Market: ABTEC matched the Norwegian Market which returned 4.6% over the past year.
Price Volatility
| ABTEC volatility | |
|---|---|
| ABTEC Average Weekly Movement | 8.7% |
| Chemicals Industry Average Movement | 6.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in NO Market | 10.3% |
| 10% least volatile stocks in NO Market | 3.0% |
Stable Share Price: ABTEC's share price has been volatile over the past 3 months.
Volatility Over Time: ABTEC's weekly volatility has decreased from 17% to 9% over the past year, but is still higher than 75% of Norwegian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 4 | Havard Lindstrom | aquabiotechnology.com |
Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics.
Aqua Bio Technology ASA Fundamentals Summary
| ABTEC fundamental statistics | |
|---|---|
| Market cap | kr304.55m |
| Earnings (TTM) | -kr1.50m |
| Revenue (TTM) | kr13.82m |
22.0x
P/S Ratio-202.7x
P/E RatioIs ABTEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABTEC income statement (TTM) | |
|---|---|
| Revenue | kr13.82m |
| Cost of Revenue | kr4.50m |
| Gross Profit | kr9.32m |
| Other Expenses | kr10.82m |
| Earnings | -kr1.50m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.026 |
| Gross Margin | 67.43% |
| Net Profit Margin | -10.88% |
| Debt/Equity Ratio | 264.7% |
How did ABTEC perform over the long term?
See historical performance and comparison